TFM
ABMD

TFC Financial Management’s Abiomed Inc ABMD Stock Holding History

TFC Financial Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-117
Closed -$29K – 568
2022
Q3 		$29K Hold
117
– – 0.01% 230
2022
Q2 		$29K Hold
117
– – 0.01% 230
2022
Q1 		$39K Hold
117
– – 0.01% 217
2021
Q4 		$42K Hold
117
– – 0.01% 225
2021
Q3 		$38K Hold
117
– – 0.01% 222
2021
Q2 		$37K Hold
117
– – 0.01% 223
2021
Q1 		$37K Hold
117
– – 0.01% 212
2020
Q4 		$38K Hold
117
– – 0.02% 208
2020
Q3 		$32K Buy
+117
New +$33.7K 0.02% 204

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TFC Financial Management's ABMD Position: Q4 2022 in Review

TFC Financial Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 117 shares — an estimated $29K sold.

TFC Financial Management first reported a position in ABMD in Q3 2020 and held it in 9 quarters. The position peaked at $42K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • TFC Financial Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • TFC Financial Management sold 117 Abiomed Inc shares in Q4 2022, an estimated $29K.
  • TFC Financial Management first reported a position in Abiomed Inc in Q3 2020 and held it in 9 quarters.
  • TFC Financial Management's Abiomed Inc position peaked at $42K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on TFC Financial Management's 13F filing for Q4 2022, filed 13 Feb 2023.